GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **1001 - 1025** of **4050** in total

« First

‹ Prev

…

37

38

39

40

41

42

43

44

45

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▲
IgM	Patient 3	-180	mild	G32473MI	59
IgG	Patient 3	4	mild	G77974XY	59
IgG	Patient 4	12	mild	G51872EK	59
IgM	Patient 1	10	moderate	G03499BP	60
IgM	Patient 1	10	moderate	G65889KE	60
IgM	Patient 1	22	moderate	G92823JK	60
IgG	Patient 2	15	mild	G82096UQ	60
IgM	Patient 2	24	mild	G78074HX	60
IgG	Patient 3	-180	mild	G30839DN	60
IgG	Patient 4	12	mild	G61751GZ	60
IgG	Patient 1	22	moderate	G08340FW	61
IgG	Patient 1	22	moderate	G68461PT	61
IgG	Patient 1	22	moderate	G75896PD	61
IgM	Patient 1	10	moderate	G25559RS	61
IgM	Patient 1	6	moderate	G03499BP	61
IgG	Patient 2	24	mild	G03499BP	61
IgM	Patient 2	15	mild	G43534QA	61
IgG	Patient 2	3	mild	G82779CI	61
IgM	Patient 2	3	mild	G37383BH	61
IgM	Patient 3	-180	mild	G47566FL	61
IgG	Patient 3	4	mild	G51872EK	61
IgG	Patient 3	4	mild	G62826CL	61
IgG	Patient 4	12	mild	G22768VO	61
IgG	Patient 1	10	moderate	G94576MN	62
IgM	Patient 1	10	moderate	G82942ZJ	62